0001261380-16-000074.txt : 20160309 0001261380-16-000074.hdr.sgml : 20160309 20160309192518 ACCESSION NUMBER: 0001261380-16-000074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160308 FILED AS OF DATE: 20160309 DATE AS OF CHANGE: 20160309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Steckel Ronald CENTRAL INDEX KEY: 0001304121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 161495805 MAIL ADDRESS: STREET 1: C/O FOXHOLLOW TECHNOLOGIES, INC. STREET 2: 740 BAY ROAD CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-03-08 0001006045 IRIDEX CORP IRIX 0001304121 Steckel Ronald 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 VP, Operations Common Stock 2016-03-08 4 M 0 6250 3.99 A 75125 D Common Stock 2016-03-08 4 S 0 6250 10.4481 D 68875 D Common Stock 2016-03-08 4 M 0 3750 3.856 D 72625 D Common Stock 2016-03-08 4 S 0 3750 10.4481 D 68875 D Common Stock 2016-03-08 4 S 0 2000 10.4625 D 66875 D Stock Option Right to Buy 3.99 2016-03-08 4 M 0 6250 0 D 2013-04-16 2019-04-16 Common Stock 6250 2083 D Stock Option Right to Buy 3.856 2016-03-08 4 M 0 3750 0 D 2013-02-01 2017-01-01 Common Stock 3750 6250 D The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $10.44 to $10.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3. The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month. /s/ Susan Bruce, Attorney-in-Fact for Ronald Steckel 2016-03-09